Log in

Hipgnosis Songs Fund Share Forecast, Price & News

GBX 117.09
+1.59 (+1.38 %)
(As of 09/29/2020 12:00 AM ET)
Today's Range
Now: GBX 117.09
50-Day Range
MA: GBX 120.87
52-Week Range
Now: GBX 117.09
Volume1.32 million shs
Average Volume1.37 million shs
Market Capitalization£721.10 million
P/E Ratio19.20
Dividend Yield4.15%

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.91 out of 5 stars

Industry, Sector and Symbol

Industry N/A



Sales & Book Value

Annual Sales£9.48 million
Cash FlowGBX 11.60 per share
Book ValueGBX 100.90 per share



Market Cap£721.10 million
Next Earnings DateN/A
OptionableNot Optionable
GBX 117.09
+1.59 (+1.38 %)
(As of 09/29/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SONG News and Ratings via Email

Sign-up to receive the latest news and ratings for SONG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Hipgnosis Songs Fund (LON:SONG) Frequently Asked Questions

How has Hipgnosis Songs Fund's stock price been impacted by Coronavirus (COVID-19)?

Hipgnosis Songs Fund's stock was trading at GBX 101 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SONG shares have increased by 15.9% and is now trading at GBX 117.09.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Hipgnosis Songs Fund?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hipgnosis Songs Fund in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Hipgnosis Songs Fund

How often does Hipgnosis Songs Fund pay dividends? What is the dividend yield for Hipgnosis Songs Fund?

Hipgnosis Songs Fund announced a dividend on Friday, July 3rd. Investors of record on Thursday, July 16th will be given a dividend of GBX 1.25 per share on Friday, July 31st. This represents a yield of 1.07%. The ex-dividend date is Thursday, July 16th. The official announcement can be accessed at this link.
View Hipgnosis Songs Fund's dividend history

What price target have analysts set for SONG?

1 equities research analysts have issued 12-month target prices for Hipgnosis Songs Fund's shares. Their forecasts range from GBX 130 to GBX 130. On average, they anticipate Hipgnosis Songs Fund's stock price to reach GBX 130 in the next twelve months. This suggests a possible upside of 11.0% from the stock's current price.
View analysts' price targets for Hipgnosis Songs Fund

What other stocks do shareholders of Hipgnosis Songs Fund own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hipgnosis Songs Fund investors own include Analog Devices (ADI), CONMED (CNMD), Walmart (WMT), BBVA Banco Frances (BBAR), Basic Energy Services (BAS), Bank of America (BAC), AXT (AXTI), American Express (AXP), Broadcom (AVGO) and ASGN (ASGN).

What is Hipgnosis Songs Fund's stock symbol?

Hipgnosis Songs Fund trades on the London Stock Exchange (LON) under the ticker symbol "SONG."

How do I buy shares of Hipgnosis Songs Fund?

Shares of SONG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Hipgnosis Songs Fund's stock price today?

One share of SONG stock can currently be purchased for approximately GBX 117.09.

How big of a company is Hipgnosis Songs Fund?

Hipgnosis Songs Fund has a market capitalization of £721.10 million and generates £9.48 million in revenue each year.

This page was last updated on 10/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.